Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

Delayed Quote. Delayed  - 07/26 07:55:33 pm
43.561 USD   +0.35%
07/20DJABBOTT LABORATO : Results, Helped by Product Launches, Top Views
07/20 ABBOTT LABORATO : CEO remains noncommittal on Alere deal
07/20DJSt. Jude Medical Logs Double-Digit Sales Growth -- Update
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales21 84820 24720 40520 91522 11323 410
Operating income (EBITDA)4 9745 8624 8505 0165 4495 867
Operating profit (EBIT)4 0464 3143 9794 0864 5854 790
Pre-Tax Profit (EBT)2 521-----
Net income2 5762 2844 4232 3773 3323 614
P/E ratio23,730,215,423,718,917,0
EPS ( $ )1,621,492,921,832,302,55
Dividend per Share ( $ )0,640,900,981,041,141,24
Yield1,67%2,00%2,18%2,40%2,63%2,85%
Reference price ( $ )38.3345.0244.9143.4143.4143.41
Announcement Date01/22/2014
12:44pm
01/29/2015
12:45pm
01/28/2016
12:31pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt3 0863 7822 8762 6553 1342 928
Finance------
Operating income (EBITDA)4 9745 8624 8505 0165 4495 867
Leverage
(Debt/EBITDA)
0,62x0,65x0,59x0,53x0,58x0,50x
Capital Expenditure1 1451 0771 1101 1331 1661 261
Book Value Per Share (BVPS)16,3 $14,3 $14,4 $13,5 $16,5 $17,8 $
Cash Flow per Share2,11 $2,41 $1,97 $2,41 $3,32 $3,48 $
Announcement Date01/22/2014
12:44pm
01/29/2015
12:45pm
01/28/2016
12:31pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 63 776 M$ -
Entreprise Value (EV) 66 431 M$ 66 909 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 23,7x 18,9x
Capitalization / Revenue 3,05x 2,88x
EV / Revenue 3,18x 3,03x
EV / EBITDA 13,2x 12,3x
Yield (DPS / Price) 2,40% 2,63%
Price to book (Price / BVPS) 3,21x 2,63x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 19,5% 20,7%
operating Leverage (Delta EBIT / Delta Sales) 1,07x 2,13x
Net Margin (Net Profit / Revenue) 11,4% 15,1%
ROA (Net Profit / Asset) 7,78% 9,49%
ROE (Net Profit / Equities) 15,7% 15,9%
Rate of Dividend 56,9% 49,6%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   5,42% 5,27%
Cash Flow / Sales 17,0% 22,1%
Capital Intensity (Assets / Sales) 1,46x 1,59x
Financial Leverage (Net Debt / EBITDA) 0,53x 0,58x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend